Ebv-positive Diffuse Large B-cell Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2013-07-25
Clinical Trial Update: Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of Elderly [NA]
A clinical trial evaluating Brentuximab vedotin for CD30-positive EBV-positive diffuse large B-cell lymphoma in elderly patients has been wi…